|
|
||||||||
GENETICALLY MODIFIED ANIMALS AND MODEL ORGANISMS
1Institute of Veterinary Physiology, Vetsuisse Faculty and Zurich Center for Integrative Human Physiology (ZIHP), 4Department of Pathology, and 5Institute of Anatomy, University of Zurich, Zurich; 3Institute of Anatomy, University of Berne, Berne; 6RCC Ltd, Itingen, Switzerland; and 2Division of Physiology, Department of Medicine, University of California San Diego, La Jolla, California
Submitted 6 March 2006 ; accepted in final form 8 May 2006
To investigate the consequences of inborn excessive erythrocytosis, we made use of our transgenic mouse line (tg6) that constitutively overexpresses erythropoietin (Epo) in a hypoxia-independent manner, thereby reaching hematocrit levels of up to 0.89. We detected expression of human Epo in the brain and, to a lesser extent, in the lung but not in the heart, kidney, or liver of tg6 mice. Although no acute cardiovascular complications are observed, tg6 animals have a reduced lifespan. Decreased swim performance was observed in 5-mo-old tg6 mice. At about 7 mo, several tg6 animals developed spastic contractions of the hindlimbs followed by paralysis. Morphological analysis by light and electron microscopy showed degenerative processes in liver and kidney characterized by increased vascular permeability, chronic progressive inflammation, hemosiderin deposition, and general vasodilatation. Moreover, most of the animals showed severe nerve fiber degeneration of the sciatic nerve, decreased number of neuromuscular junctions, and degeneration of skeletal muscle fibers. Most probably, the developing demyelinating neuropathy resulted in muscular degeneration demonstrated in the extensor digitorum longus muscle. Taken together, chronically increased Epo levels inducing excessive erythrocytosis leads to multiple organ degeneration and reduced life expectancy. This model allows investigation of the impact of excessive erythrocytosis in individuals suffering from polycythemia vera, chronic mountain sickness, or in subjects tempted to abuse Epo by means of gene doping.
chronic mountain sickness; erythropoietin doping; neurodegeneration; neuromuscular junctions; polycythemia; vascular permeability
This article has been cited by other articles:
![]() |
J. Soliz, C. Soulage, D. M. Hermann, and M. Gassmann Acute and chronic exposure to hypoxia alters ventilatory pattern but not minute ventilation of mice overexpressing erythropoietin Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2007; 293(4): R1702 - R1710. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Foller, R. S. Kasinathan, S. Koka, S. M. Huber, B. Schuler, J. Vogel, M. Gassmann, and F. Lang Enhanced susceptibility to suicidal death of erythrocytes from transgenic mice overexpressing erythropoietin Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R1127 - R1134. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Bogdanova, D. Mihov, H. Lutz, B. Saam, M. Gassmann, and J. Vogel Enhanced erythro-phagocytosis in polycythemic mice overexpressing erythropoietin Blood, July 15, 2007; 110(2): 762 - 769. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Robach, G. Cairo, C. Gelfi, F. Bernuzzi, H. Pilegaard, A. Vigano, P. Santambrogio, P. Cerretelli, J. A. L. Calbet, S. Moutereau, et al. Strong iron demand during hypoxia-induced erythropoiesis is associated with down-regulation of iron-related proteins and myoglobin in human skeletal muscle Blood, June 1, 2007; 109(11): 4724 - 4731. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |